Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
09/2005
09/29/2005WO2005090357A1 Tricyclic benzopyran compound as anti-arrhythmic agents
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005089754A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005WO2005054234A3 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2557054A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/28/2005EP1578743A2 Antibacterial agents
09/28/2005EP1578732A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578425A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
09/28/2005EP1578341A2 Modulation of ccr4 function
09/28/2005CN1675225A Macrocyclic pyrimidines, their production and use as pharmaceutical agents
09/27/2005US6949651 A thiazolo(5,4-b)pyridine-5,7-dione derivatives for treating arthritis, inflammation, cancer
09/27/2005US6949643 Thiazolopytimidines and their use as modulators of chemokine receptor activity
09/27/2005US6949562 Heterocyclic compounds as ligands of the GABAA receptor
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1577301A1 Diamine derivatives
09/21/2005EP1575963A1 Therapeutic agents
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
09/21/2005CN1671707A Novel process for producting imidazo[1, 2-b]pyridazine derivative
09/21/2005CN1671690A Antimicrobial aza-bicyclic derivates, their compositions and uses
09/21/2005CN1671675A 2, 1, 3-benzothiadiazoles for use as electronic active components
09/21/2005CN1670021A Compound with pine wood nematode killing activity with poison and use thereof
09/20/2005US6946478 Compounds
09/20/2005US6946473 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
09/15/2005WO2005085242A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005WO2005085234A2 Bycyclic anthranilamide derivatives useful as insecticides
09/15/2005WO2005085219A1 Isothiourea derivatives
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
09/15/2005US20050203154 Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/15/2005CA2556386A1 Isothiourea derivatives
09/14/2005EP1572693A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
09/14/2005EP1572682A2 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
09/14/2005EP1572668A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
09/14/2005EP1572207A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
09/14/2005EP1461318B1 Tetrahydroquinoline analogues as muscarinic agonists
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/13/2005US6943167 Helix mimetics and composition and methods related thereto
09/13/2005US6943159 amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor agonists or antagonists such as 3-Cyclohexyl-7-(1-hydroxyethyl)-1,2,3,4-tetrahydro-1,2,4-benzothiadiazine-1,1-dioxide, used for prophylaxis of nervous system disoders
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197333 Rifamycin analogs and uses thereof
09/08/2005US20050197330 Heterocyclic GABAA subtype selective receptor modulators
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/06/2005CA2137673C Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives
09/01/2005WO2005080399A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
08/2005
08/31/2005EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
08/31/2005CN1662544A Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method
08/30/2005US6936631 Bicyclic imidazo-5-yl-amine derivatives
08/30/2005US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936189 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
08/25/2005WO2005077959A1 Pth agonists
08/25/2005WO2005077897A1 Substituted azetidine compounds, their preparation and use as medicaments
08/25/2005WO2005077363A1 Heterocyclic gaba-a subtype selective receptor modulators
08/25/2005WO2005063764A3 Fused pyrrolocarbazoles and methods for the preparation thereof
08/25/2005WO2005056563A3 Process for the preparation of thiazolopyrimidines
08/25/2005WO2005026208A3 Chimeric gabab receptor
08/25/2005US20050187313 Process for aqueous milling of quinacridone pigments
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187214 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders
08/25/2005US20050187208 Substituted Azetidine compounds, their preparation and use as medicaments
08/25/2005US20050183635 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone
08/25/2005CA2556565A1 Substituted azetidine compounds, their preparation and use as medicaments
08/25/2005CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators
08/24/2005EP1566380A1 Isoquinoline compounds and medicinal use thereof
08/24/2005EP1565459A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/18/2005WO2005075600A1 Organic element for electroluminescent devices
08/18/2005WO2005075477A1 Antibacterial compounds
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182047 Treatment of demyelinating disorders
08/17/2005EP1564213A1 Imidazole derivative, process for producing the same, and use
08/17/2005EP1562958A1 N-sulfonylaminothiazole
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 152